ADMA Biologics Inc.
ADMA | NASDAQ
$9.51
+$0.40 (+4.39%)
At close: Sep 21, 2026, 4:00 PM ET
$9.29
-$0.22 (-2.36%)
Pre-market:
Sep 22, 2026, 5:30 AM ET
Market Data
Market Cap $2.11B
Enterprise Value $2.27B
Beta 0.77
Average Volume 4.45M
Shares Outstanding (Diluted) 230.34M
Shares Change YoY -7.35%
Institutional Ownership 89.78%
Exchange NASDAQ
ISIN US0008991046
Price Performance
Price Change 1M -3.0%
Price Change 3M 9.4%
Price Change 6M -1.3%
Price Change YTD -46.8%
Price Change 1Y -40.7%
Price Change 3Y 170.9%
Price Change 5Y 660.8%
1M CAGR (ann.) -9.4%
1Y CAGR (ann.) -41.5%
5Y CAGR (ann.) 50.2%
All-Time CAGR 0.5%
Valuation
PE Ratio 13.59
Forward PE 9.48
PEG Ratio -0.73
Forward PEG 0.69
PS Ratio 4.30
Forward PS 3.50
PB Ratio 5.40
P/FCF Ratio 18.91
P/Adj. FCF Ratio 23.54
P/OCF Ratio 15.85
EV/Sales 4.43
EV/EBIT 10.08
EV/EBITDA 9.67
EV/FCF 19.50
Earnings Yield 7.4%
FCF Yield 5.3%
Adj. FCF Yield 4.3%
Financial Health
Net Debt $60.57M
Total Debt $203.84M
Cash & Short-Term Investments $136.02M
Total Assets $684.21M
Current Ratio 6.97
Quick Ratio 3.81
Debt / Equity Ratio 0.50
Debt / EBITDA 0.87
Debt / FCF 1.75
OCF / Debt 0.67
Interest Coverage 24.53
Altman Z-Score 7.06
Piotroski F-Score 5
Margins & Profitability
Gross Profit Margin 64.7%
Operating Profit Margin 42.3%
EBITDA Margin 45.8%
Net Profit Margin 33.0%
FCF Margin 22.7%
Adj. FCF Margin 18.3%
SBC / Revenue 4.5%
SBC Impact (per share) -19.7%
Returns
Return on Assets 24.7%
Return on Equity 39.6%
Return on Invested Capital 27.6%
Return on Capital Employed 35.6%
Return on Tangible Assets 24.8%
Historical Growth (CAGR)
Revenue CAGR 3Y 35.0%
Revenue CAGR 5Y 54.5%
Revenue CAGR 10Y 50.2%
EPS CAGR 3Y 49.4%
EPS CAGR 5Y 176.0%
EPS CAGR 10Y 56.4%
FCF CAGR 3Y 30.0%
FCF CAGR 5Y 278.1%
FCF CAGR 10Y 63.6%
Analyst Forecasts
Analyst Rating Buy
Analyst Count 10
EPS Growth Next 3Y 26.6%
Revenue Growth Next 3Y 17.8%
Earnings Date Nov 3, 2026
EPS Estimate (next Q) $0.19
EPS Growth Est (next Q) 18.8%
Revenue Est (next Q) $138.12M
Revenue Growth Est (next Q) 2.9%
Fair Value Estimates
Graham Number $5.31
Graham Upside -44.2%
Lynch Fair Value $17.50
Lynch Upside 84.0%
Price Target $18.67
Price Target Upside 96.3%
Cash Flow
Operating Cash Flow $136.72M
Free Cash Flow $116.47M
Adj. Free Cash Flow $93.57M
FCF Per Share $0.51
OCF Per Share $0.60
OCF/S Ratio 26.7%
Income Statement
Revenue $512.28M
Gross Profit $331.47M
Operating Income $216.5M
EBITDA $234.83M
Net Income $168.96M
EPS (Diluted) $0.70
Revenue / Employee $795.46K
Profit / Employee $262.36K
Employees 644
Add to Watchlist
Select watchlists to add or remove ADMA